WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel Patrick OdayChairman CEO2025-07-288,345$114.09
$952.08kSell
Daniel Patrick OdayChairman CEO2025-07-281,655$113.17
$187.29kSell
Deborah H. TelmanEVP Corporate Affairs GC2025-07-253,823$116.20
$444.23kSell
Johanna MercierChief Commercial Officer2025-07-153,000$111.03
$333.09kSell
Andrew D. DickinsonChief Financial Officer2025-07-152,500$111.03
$277.58kSell
Jeffrey BluestoneDirector2025-07-145,000$109.74
$548.70kSell
Jeffrey BluestoneDirector2025-07-145,000$67.45
$337.25kBuy
Daniel Patrick OdayChairman CEO2025-06-309,400$110.40
$1.04MSell
Daniel Patrick OdayChairman CEO2025-06-30600$111.15
$66.69kSell
Johanna MercierChief Commercial Officer2025-06-163,000$110.17
$330.51kSell

1 of 10

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.62%119,364,226$14.34BInstitution
Blackrock Inc9.26%114,879,922$13.80BInstitution
Capital World Investors3.73%46,303,299$5.56BInstitution
Capital Research Global Investors2.51%31,097,679$3.74BInstitution
Dodge Cox2.48%30,818,322$3.70BInstitution
Geode Capital Management LLC2.35%29,207,662$3.51BInstitution
Norges Bank1.56%19,394,502$2.33BInstitution
Jpmorgan Chase Co1.54%19,079,591$2.29BInstitution
Northern Trust Corp1.16%14,409,323$1.73BInstitution
Bank Of New York Mellon Corp1.11%13,731,916$1.65BInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD58.10%1.11%Net SellingNet Selling
PFE47.40%0.27%Net Buying
AMGN59.76%0.99%Net SellingNet Selling
SNY14.51%0.00%
BMY60.41%0.37%Net SellingNet Selling
View Top General Drug Manufacturer Stocks

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 58.10% institutional shareholders, 1.11% Gilead Sciences insiders, and 40.79% retail investors. Vanguard Group Inc is the largest individual Gilead Sciences shareholder, owning 119.36M shares representing 9.62% of the company. Vanguard Group Inc's Gilead Sciences shares are currently valued at $14.21B.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.